Related references
Note: Only part of the references are listed.Nifedipine Induces Peroxisome Proliferator-Activated Receptor-γ Activation in Macrophages and Suppresses the Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice
Norio Ishii et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Insulin Resistance Predicts Mortality in Nondiabetic Individuals in the US
Karlee J. Ausk et al.
DIABETES CARE (2010)
Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus
Yutaka Seino et al.
JOURNAL OF DIABETES INVESTIGATION (2010)
Comparative Effects of Telmisartan and Eprosartan on Insulin Sensitivity in the Treatment of Overweight Hypertensive Patients
R. Fogari et al.
HORMONE AND METABOLIC RESEARCH (2009)
Telmisartan but not candesartan affects adiponectin expression in vivo and in vitro
Satoru Yamada et al.
HYPERTENSION RESEARCH (2008)
Diagnostic criteria for Dyslipidemia - Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese
Tamio Teramoto et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2007)
Effects of telmisartan on fat distribution in individuals with the metabolic syndrome
Michio Shimabukuro et al.
JOURNAL OF HYPERTENSION (2007)
Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program -: Comparative evaluation of three assays
Matthias Blueher et al.
DIABETES CARE (2007)
Angiotensin II receptor blockers downsize adipocytes in spontaneously type 2 diabetic rats with visceral fat obesity
Yutaka Mori et al.
AMERICAN JOURNAL OF HYPERTENSION (2007)
Molecular characterization of new selective peroxisome proliferator-activated receptor γ modulators with angiotensin receptor blocking activity
M Schupp et al.
DIABETES (2005)
Insulin-sensitizing effects of telmisartan
HA Pershadsingh et al.
DIABETES CARE (2004)
Blockade of the renin-angiotensin system decreases adipocyte size with improvement in insulin sensitivity
M Furuhashi et al.
JOURNAL OF HYPERTENSION (2004)
An angiotensin II AT1 receptor antagonist, telmisartan augments glucose uptake and GLUT4 protein expression in 3T3-L1 adipocytes
M Fujimoto et al.
FEBS LETTERS (2004)
Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-α activity
M Schupp et al.
CIRCULATION (2004)
Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARγ-modulating activity
SC Benson et al.
HYPERTENSION (2004)
Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice
T Shiuchi et al.
HYPERTENSION (2004)
Association of hypoadiponectinemia with coronary artery disease in men
M Kumada et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Impact of elevated blood pressure on mortality from all causes, cardiovascular diseases, heart disease and stroke among Japanese: 14 year follow-up of randomly selected population from Japanese - Nippon data 80
H Ueshima et al.
JOURNAL OF HUMAN HYPERTENSION (2003)
Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors
J Janke et al.
DIABETES (2002)
Vascular protective effects by activation of nuclear receptor PPAR gamma
S Wakino et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2002)
Therapeutic potential of angiotensin II receptor antagonists
M White et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2001)
Share Paper
